Refractory Epidermolysis Bullosa Acquisita Treated With Apremilast
- 20 September 2026
- journal article
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (11)
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosisJournal of the American Academy of Dermatology, 2021
- Epidermolysis Bullosa Acquisita: The 2019 UpdateFrontiers in Medicine, 2019
- Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patientsOrphanet Journal of Rare Diseases, 2018
- PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa AcquisitaJournal of Investigative Dermatology, 2016